Eatontown, NJ, November, 14 2016. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Trospium 20mg tablets. This launch adds to Avet’s robust portfolio of generic oral solid products. Trospium is the AB rated generic equivalent to the antispasmodic drug Sanctura®. It is indicated for the treatment of overactive bladder symptoms, such as incontinence, urgency and frequency. According to IMS data for the twelve-months ended September 2016, the U.S. market for Trospium tablets is approximately $17 million.